Stock listing
OTC:PURE PURE Bioscience Stock
Follow PURE Bioscience into a list and get an email when it puts out news.
Share price · OTC:PURE
$0.055 USD -0.003 (-5.2%)
Close on Nov 20, 2026
- Day range
- $0.045 – $0.055 USDNov 20, 2026
- Volume
- 10,987 sharesNov 20, 2026
- Market cap
- $7.71M USDAt the close on Nov 20, 2026 · price × 140.2M shares outstanding
- 52-week range
- $0.040 – $0.100 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1,675 USDMedian day 10,275 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:PURE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.055 | -0.003 | -5.2% | $0.050 | $0.055 | $0.045 | 10,987 | |
| $0.058 | -0.001 | -1.7% | $0.058 | $0.058 | $0.058 | 7,000 | |
| $0.059 | -0.001 | -1.7% | $0.059 | $0.059 | $0.059 | 3,451 | |
| $0.060 | -0.010 | -14.3% | $0.060 | $0.060 | $0.060 | 5,988 | |
| $0.070 | 0.000 | 0.0% | $0.058 | $0.070 | $0.058 | 7,800 | |
| $0.070 | +0.005 | +7.7% | $0.070 | $0.070 | $0.070 | 250 | |
| $0.065 | -0.005 | -7.1% | $0.070 | $0.070 | $0.065 | 14,000 | |
| $0.070 | +0.005 | +7.7% | $0.070 | $0.070 | $0.070 | 7,000 | |
| $0.065 | 0.000 | 0.0% | $0.065 | $0.065 | $0.065 | 2,622 | |
| $0.065 | +0.003 | +4.8% | $0.057 | $0.065 | $0.057 | 27,885 | |
| $0.062 | -0.003 | -4.6% | $0.062 | $0.062 | $0.062 | 20,500 | |
| $0.065 | -0.005 | -7.1% | $0.070 | $0.070 | $0.062 | 15,413 | |
| $0.070 | -0.002 | -2.8% | $0.062 | $0.075 | $0.062 | 7,700 | |
| $0.072 | -0.003 | -4.0% | $0.070 | $0.072 | $0.062 | 34,025 | |
| $0.075 | 0.000 | -0.1% | $0.071 | $0.075 | $0.065 | 10,275 | |
| $0.075 | +0.002 | +2.7% | $0.075 | $0.075 | $0.075 | 275 | |
| $0.073 | -0.014 | -16.0% | $0.073 | $0.075 | $0.071 | 12,100 | |
| $0.087 | 0.000 | 0.0% | $0.087 | $0.087 | $0.087 | 225 | |
| $0.087 | -0.003 | -3.3% | $0.087 | $0.087 | $0.087 | 7,800 | |
| $0.090 | +0.010 | +12.5% | $0.070 | $0.090 | $0.070 | 22,500 | |
| $0.080 | 0.000 | 0.0% | $0.070 | $0.090 | $0.070 | 24,200 | |
| $0.080 | +0.010 | +14.3% | $0.070 | $0.080 | $0.070 | 1,900 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.080 | $0.070 | 20,700 | |
| $0.070 | -0.010 | -12.5% | $0.070 | $0.070 | $0.070 | 25,200 | |
| $0.080 | +0.010 | +14.3% | $0.080 | $0.080 | $0.070 | 1,700 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 3,600 | |
| $0.070 | -0.010 | -12.5% | $0.070 | $0.080 | $0.070 | 8,000 | |
| $0.080 | 0.000 | 0.0% | $0.080 | $0.080 | $0.070 | 34,500 | |
| $0.080 | 0.000 | 0.0% | $0.080 | $0.080 | $0.080 | 0 | |
| $0.080 | 0.000 | 0.0% | $0.090 | $0.090 | $0.080 | 8,200 | |
| $0.080 | -0.010 | -11.1% | $0.090 | $0.090 | $0.080 | 1,600 | |
| $0.090 | +0.010 | +12.5% | $0.080 | $0.090 | $0.080 | 18,000 | |
| $0.080 | +0.010 | +14.3% | $0.070 | $0.090 | $0.060 | 209,400 | |
| $0.070 | +0.010 | +16.7% | $0.070 | $0.070 | $0.070 | 60,600 | |
| $0.060 | -0.010 | -14.3% | $0.060 | $0.070 | $0.060 | 14,300 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 6,500 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 25 | |
| $0.070 | +0.010 | +16.7% | $0.070 | $0.070 | $0.070 | 1,500 | |
| $0.060 | -0.010 | -14.3% | $0.060 | $0.070 | $0.060 | 340,700 | |
| $0.070 | +0.010 | +16.7% | $0.070 | $0.070 | $0.070 | 400 | |
| $0.060 | -0.010 | -14.3% | $0.060 | $0.060 | $0.060 | 500 | |
| $0.070 | +0.010 | +16.7% | $0.070 | $0.070 | $0.070 | 20,200 | |
| $0.060 | 0.000 | 0.0% | $0.070 | $0.070 | $0.060 | 12,000 | |
| $0.060 | -0.010 | -14.3% | $0.070 | $0.070 | $0.060 | 4,100 | |
| $0.070 | -0.010 | -12.5% | $0.070 | $0.070 | $0.070 | 1,000 | |
| $0.080 | +0.010 | +14.3% | $0.060 | $0.080 | $0.060 | 3,700 | |
| $0.070 | -0.010 | -12.5% | $0.060 | $0.080 | $0.060 | 54,000 | |
| $0.080 | +0.010 | +14.3% | $0.070 | $0.080 | $0.070 | 21,200 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.060 | 3,900 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 14,300 | |
| $0.070 | 0.000 | 0.0% | $0.080 | $0.080 | $0.070 | 3,500 | |
| $0.070 | -0.010 | -12.5% | $0.070 | $0.080 | $0.060 | 26,100 | |
| $0.080 | +0.010 | +14.3% | $0.060 | $0.080 | $0.060 | 21,900 | |
| $0.070 | 0.000 | 0.0% | $0.060 | $0.070 | $0.060 | 11,000 | |
| $0.070 | +0.010 | +16.7% | $0.060 | $0.070 | $0.050 | 27,400 | |
| $0.060 | -0.020 | -25.0% | $0.060 | $0.070 | $0.040 | 145,400 | |
| $0.080 | 0.000 | 0.0% | $0.060 | $0.080 | $0.060 | 16,000 | |
| $0.080 | -0.010 | -11.1% | $0.060 | $0.080 | $0.060 | 2,200 | |
| $0.090 | +0.020 | +28.6% | $0.090 | $0.090 | $0.090 | 1,400 | |
| $0.070 | -0.010 | -12.5% | $0.060 | $0.070 | $0.060 | 33,000 | |
| $0.080 | +0.020 | +33.3% | $0.090 | $0.090 | $0.080 | 10,300 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 4,860 | |
| $0.060 | 0.000 | 0.0% | $0.090 | $0.090 | $0.060 | 37,556 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | -0.030 | -33.3% | $0.090 | $0.090 | $0.060 | 123,100 |
Splits
2 splits since 2000 · OTC:PURE · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-8 | Consolidation | |
| 51-for-50 | Split |
- Ticker
- OTC:PURE
- Asset type
- Stock
- Sector
- Chemicals & materials
- Industry
- Chemicals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
PURE Bioscience Reports Fiscal 2026 Financial Results
Latest news
PURE Bioscience Reports Fiscal 2026 Financial Results
Oct 29, 2026
Closed $0.075 (-0.1%) on Oct 30, 2026
PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results
Jun 15, 2026
Closed $0.06 (-14.3%) on Jun 16, 2026
PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results
Mar 16, 2026
Closed $0.08 (0.0%) on Mar 17, 2026
PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results
Dec 15, 2025
Closed $0.05 (0.0%) on Dec 16, 2025
PURE Bioscience on 6ix
- Sector
- Chemicals & materials
- Industry
- Chemicals
- News releases
- 4 in the last 12 months · 172 in all · newest Oct 29, 2026 · oldest 2013
Valuation
EV/sales 5.9× against a median of 0.5×: the highest of 10 Chemicals companies shown. Statements: Year to Jul 31, 2026 · price Nov 20, 2026
- Enterprise value
- $13.74M USD
- P/E
- Loss
- EV/sales
- 5.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- 57.3%
- Operating margin
- −90.0%
- Net margin
- −107.3%
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.09
Chemicals: the 10 companies nearest in size, of 628 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| PURE Bioscience · OTC:PURE | US$7.71M | US$13.74M | n/a | 5.9× | n/a | n/a | −107.3% | n/a | 0.09 |
| PT Intanwijaya Internasional Tbk · IDX:INCI | US$9.15M | US$150,368 | n/a | n/a | n/a | 0.4× | n/a | 0.0× | n/a |
| Thai Poly Acrylic Public Co. Ltd. · SET:TPA | US$9.02M | US$5.88M | 50.9× | 0.4× | 15.0× | 0.8× | 1.2% | 0.0× | n/a |
| B.I.G. Industries Bhd. · MYX:BIG | US$8.96M | US$2.80M | 9.8× | 0.3× | 0.9× | 0.7× | 9.5% | 0.1× | n/a |
| UBIS (Asia) PCL · SET:UBIS | US$8.81M | US$12.46M | 5.7× | 0.5× | 5.5× | 0.4× | 5.6% | 0.4× | n/a |
| Alkali Metals Ltd. · NSE:ALKALI | US$8.40M | US$10.48M | 30.5× | 1.0× | 14.3× | 1.8× | 2.6% | 0.5× | n/a |
| Vineet Laboratories Ltd. · NSE:VINEETLAB | US$8.30M | US$11.31M | 22.0× | 1.7× | 10.1× | 1.7× | 5.6% | 1.0× | n/a |
| OrganoClick AB · OMXSTO:ORGC | US$7.88M | US$15.52M | n/a | 1.8× | n/a | 7.7× | −35.7% | 7.5× | n/a |
| Tribox Group AB Class B · OMXSTO:TRIBO_B | US$7.47M | US$8.01M | 53.7× | 0.5× | 7.5× | 1.6× | 0.9% | 0.5× | n/a |
| TOR Minerals International, Inc. · OTC:TORM | US$6.55M | US$4.11M | n/a | 0.2× | 3.8× | 0.4× | −2.1% | 0.1× | 0.61 |
| Encres Dubuit SA · EURONEXT:ALDUB | US$6.10M | US$3.80M | n/a | 0.1× | 3.0× | 0.4× | −9.6% | 0.1× | n/a |
| Median of the others | US$8.35M | US$6.94M | 26.3× | 0.5× | 6.5× | 0.8× | 1.2% | 0.3× | 0.61 |
Team and board
Officers
| Officer | Role |
|---|---|
| Robert Bartlett | CEO |
| Jeff Kitchell | President, |
| James L. Marsden | Executive Leader |
Board
| Director | Role |
|---|---|
| Ivan Chen | Chairman of the Board |
| Bernard Blotner | Board Member |
| Darin Zehr | Board Member |
| David M. Rendall | Board Member |
| Robert Bartlett | CEO |
| Tom Myers | Board Member |
| Tom Y. Lee | Board Member |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Jun 16, 2026 | 0.0% |
| Q2 2026 | Mar 18, 2026 | 0.0% |
| Q1 2026 | Dec 15, 2025 | 0.0% |
| Q4 2025 | Oct 29, 2025 | −12.5% |
| Q3 2025 | Jun 12, 2025 · Before open | 0.0% |
| Q2 2025 | Mar 17, 2025 · Before open | 0.0% |
| Q1 2025 | Dec 12, 2024 · Before open | −14.3% |
| Q4 2024 | Oct 29, 2024 · After close | 0.0% |
| Q3 2024 | Jun 14, 2024 · After close | +7.0% |
| Q2 2024 | Mar 18, 2024 · After close | 0.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Dec 14, 2023 · After close | −6.3% |
| Q4 2023 | Oct 30, 2023 · After close | −20.0% |
| Q3 2023 | Jun 14, 2023 · After close | −30.8% |
| Q2 2023 | Mar 17, 2023 · After close | −18.8% |
| Q1 2023 | Dec 14, 2022 · After close | −7.1% |
| Q4 2022 | Oct 28, 2022 · After close | −10.5% |
| Q3 2022 | Jun 14, 2022 · After close | −9.5% |
| Q2 2022 | Mar 15, 2022 · After close | 0.0% |
| Q1 2022 | Dec 15, 2021 · After close | −14.8% |
| Quarter to Jul 31, 2021 | Oct 28, 2021 · After close | 0.0% |
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.31M | 2.20M | 1.96M | 1.87M | 1.81M | 3.70M | 6.92M | 1.91M | 1.77M | 1.83M |
| Cost of revenue | 992.0K | 899.0K | 811.0K | 906.0K | 853.0K | 1.85M | 2.90M | 728.0K | 763.0K | 760.0K |
| Gross profit | 1.33M | 1.30M | 1.15M | 971.0K | 1.00M | 2.08M | 4.02M | 1.18M | 1.01M | 1.07M |
| Research and development | 332.0K | 316.0K | 302.0K | 297.0K | 319.0K | 339.0K | 322.0K | 354.0K | 459.0K | 779.0K |
| Selling, general and administrative | 3.08M | 3.26M | 3.98M | 4.30M | 4.05M | 4.05M | 3.69M | 6.42M | 5.24M | 5.23M |
| Operating income | -2.08M | -2.27M | -3.19M | -3.94M | -3.72M | -2.31M | 4.00K | -5.59M | -7.04M | -6.01M |
| Depreciation and amortization | 3.00K | 2.00K | 148.0K | 117.0K | 213.0K | 172.0K | 192.0K | 241.0K | 285.0K | 276.0K |
| EBITDA | -2.08M | -2.27M | -3.04M | -3.83M | -3.51M | -2.14M | 196.0K | -5.35M | -6.76M | -5.73M |
| Interest expense | 407.0K | 299.0K | 155.0K | 14.0K | 6.00K | 4.00K | 5.00K | 6.00K | 8.00K | |
| Income tax | 0 | 0 | 0 | 0 | 1.65K | 1.65K | 1.65K | 1.65K | 1.65K | 1.65K |
| Net income | -2.48M | -2.40M | -3.35M | -3.96M | -3.49M | -2.32M | 4.00K | -6.55M | -7.44M | -6.26M |
| Earnings per share, basic | -0.02 | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 | 0.00 | -0.09 | -0.11 | -0.10 |
| Earnings per share, diluted | -0.02 | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 | 0.00 | -0.09 | -0.11 | -0.10 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 569.0K | 334.0K | 349.0K | 1.09M | 3.39M | 2.39M | 3.84M | 398.0K | 851.0K | 1.64M |
| Receivables | 334.0K | 474.0K | 298.0K | 285.0K | 201.0K | 368.0K | 1.09M | 373.0K | 275.0K | 297.0K |
| Inventory | 193.0K | 141.0K | 56.0K | 88.0K | 179.0K | 332.0K | 547.0K | 177.0K | 197.0K | 273.0K |
| Current assets | 1.19M | 1.05M | 805.0K | 1.60M | 3.86M | 3.20M | 5.57M | 1.04M | 1.46M | 2.46M |
| Property, plant and equipment | 8.00K | 11.0K | 13.0K | 221.0K | 620.0K | 740.0K | 316.0K | 362.0K | 461.0K | 548.0K |
| Total assets | 1.19M | 1.06M | 818.0K | 1.82M | 4.48M | 4.30M | 6.32M | 1.93M | 2.58M | 3.83M |
| Accounts payable | 820.0K | 784.0K | 601.0K | 422.0K | 488.0K | 593.0K | 1.34M | 553.0K | 608.0K | 426.0K |
| Current liabilities | 4.37M | 2.11M | 733.0K | 532.0K | 575.0K | 970.0K | 1.51M | 738.0K | 1.28M | 2.53M |
| Total debt | 6.60M | |||||||||
| Total liabilities | 7.59M | 6.17M | 3.68M | 1.55M | 575.0K | 970.0K | 1.51M | 742.0K | 1.29M | 2.54M |
| Shareholders' equity | -6.40M | -5.12M | -2.86M | 272.0K | 3.91M | 3.33M | 4.81M | 1.19M | 1.28M | 1.29M |
| Shares outstanding | 130.0M | 111.9M | 111.9M | 111.9M | 111.4M | 87.2M | 87.1M | 76.7M | 68.2M | 63.1M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.74M | -2.02M | -2.53M | -3.28M | -2.42M | -1.17M | 669.0K | -2.99M | -3.89M | -4.56M |
| Capital spending | -33.0K | -81.0K | -521.0K | -58.0K | -7.00K | -19.0K | -206.0K | |||
| Free cash flow | -3.31M | -2.50M | -1.69M | 611.0K | -3.00M | -3.91M | -4.77M | |||
| Cash from investing | -33.0K | -81.0K | -521.0K | -58.0K | -13.0K | -34.0K | -226.0K | |||
| Cash from financing | 1.97M | 2.00M | 1.78M | 1.01M | 3.50M | 239.0K | 2.83M | 2.55M | 3.13M | 1.23M |
| Change in cash | 235.0K | -15.0K | -746.0K | -2.30M | 1.00M | -1.45M | 3.44M | -453.0K | -789.0K | -3.55M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-K · Annual report | Oct 29, 2026 | Annual report | SEC |
| 8-K · Current report | Oct 29, 2026 | Results | SEC |
| 8-K · Current report | Oct 20, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Jun 15, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jun 15, 2026 | Results | SEC |
| 8-K · Current report | May 5, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Mar 16, 2026 | Quarterly report | SEC |
| 8-K · Current report | Mar 16, 2026 | Results | SEC |
| 8-K · Current report | Feb 20, 2026 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Dec 30, 2025 | Meeting notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| PRE 14A · Preliminary proxy statement | Dec 18, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | Dec 15, 2025 | Quarterly report | SEC |
| 8-K · Current report | Dec 15, 2025 | Results | SEC |
| 3 · Initial statement of ownership | Nov 28, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 19, 2025 | Management or board change | SEC |
| 10-K · Annual report | Oct 29, 2025 | Annual report | SEC |
| 8-K · Current report | Oct 29, 2025 | Results | SEC |
| 10-Q · Quarterly report | Jun 16, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jun 16, 2025 | Results | SEC |
| 10-Q · Quarterly report | Mar 17, 2025 | Quarterly report | SEC |
| 8-K · Current report | Mar 17, 2025 | Results | SEC |
| 8-K · Current report | Jan 28, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Dec 16, 2024 | Quarterly report | SEC |
| 8-K · Current report | Dec 16, 2024 | Results | SEC |
| DEF 14A · Proxy statement | Dec 12, 2024 | Meeting notice | SEC |
| 10-K · Annual report | Oct 29, 2024 | Annual report | SEC |
| 8-K · Current report | Oct 29, 2024 | Results | SEC |
| 8-K · Current report | Sep 20, 2024 | Material contract | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Aug 15, 2024 | Offer document | SEC |
| 8-K · Current report | Aug 9, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Jun 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jun 14, 2024 | Results | SEC |
| 3 · Initial statement of ownership | May 13, 2024 | Insider trade | SEC |
| 8-K · Current report | May 7, 2024 | Management or board change | SEC |
| 8-K · Current report | Mar 27, 2024 | Material contract | SEC |
| 10-Q · Quarterly report | Mar 18, 2024 | Quarterly report | SEC |
| 8-K · Current report | Mar 18, 2024 | Results | SEC |
| 8-K · Current report | Feb 26, 2024 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Jan 10, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Dec 19, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Dec 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Dec 14, 2023 | Results | SEC |
| 10-K · Annual report | Oct 30, 2023 | Annual report | SEC |
| 8-K · Current report | Oct 30, 2023 | Results | SEC |
| 4 · Change in ownership | Aug 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 3, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 10, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Jun 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 14, 2023 | Results | SEC |
| 4 · Change in ownership | Mar 22, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 22, 2023 | Insider trade | SEC |
| 8-K · Current report | Mar 21, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | Mar 17, 2023 | Quarterly report | SEC |
| 8-K · Current report | Mar 17, 2023 | Results | SEC |
| 3 · Initial statement of ownership | Feb 22, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 21, 2023 | Insider trade | SEC |
| 8-K · Current report | Feb 10, 2023 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Dec 23, 2022 | Meeting notice | SEC |
| 4 · Change in ownership | Dec 19, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Dec 14, 2022 | Quarterly report | SEC |
| 8-K · Current report | Dec 14, 2022 | Results | SEC |
| 10-K · Annual report | Oct 28, 2022 | Annual report | SEC |
| 8-K · Current report | Oct 28, 2022 | Results | SEC |
| 4 · Change in ownership | Oct 4, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 4, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 4, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 4, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 4, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 4, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jul 19, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jul 19, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jul 19, 2022 | Insider trade | SEC |
| 8-K · Current report | Jul 19, 2022 | Material contract | SEC |
| 10-Q · Quarterly report | Jun 14, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jun 14, 2022 | Results | SEC |
| 4 · Change in ownership | Mar 22, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Mar 15, 2022 | Quarterly report | SEC |
| 8-K · Current report | Mar 15, 2022 | Results | SEC |
| 8-K · Current report | Feb 8, 2022 | Meeting outcome | SEC |
| S-8 · Registration statement for employee plans | Jan 26, 2022 | Offer document | SEC |
| DEF 14A · Proxy statement | Dec 20, 2021 | Meeting notice | SEC |
| 10-Q · Quarterly report | Dec 15, 2021 | Quarterly report | SEC |
| 8-K · Current report | Dec 15, 2021 | Results | SEC |
| 10-K · Annual report | Oct 28, 2021 | Annual report | SEC |
| 8-K · Current report | Oct 28, 2021 | Results | SEC |
| 8-K · Current report | Aug 23, 2021 | Current report | SEC |
| 4 · Change in ownership | Jun 24, 2021 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 24, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2021 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 22, 2021 | Insider trade | SEC |
| 10-Q · Quarterly report | Jun 15, 2021 | Quarterly report | SEC |
| 8-K · Current report | Jun 15, 2021 | Results | SEC |
| 8-K · Current report | May 19, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Mar 15, 2021 | Quarterly report | SEC |
| 8-K · Current report | Mar 15, 2021 | Results | SEC |
| 8-K · Current report | Jan 27, 2021 | Meeting outcome | SEC |
| 4 · Change in ownership | Dec 28, 2020 | Insider trade | SEC |
| 10-Q · Quarterly report | Dec 15, 2020 | Quarterly report | SEC |
| 8-K · Current report | Dec 15, 2020 | Results | SEC |
| DEF 14A · Proxy statement | Dec 8, 2020 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Nov 20, 2020 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Oct 26, 2020 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Oct 19, 2020 | Offer document | SEC |
| 10-K · Annual report | Oct 8, 2020 | Annual report | SEC |
| 8-K · Current report | Oct 8, 2020 | Results | SEC |
| 4 · Change in ownership | Jun 26, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2020 | Insider trade | SEC |
| 424B3 · Prospectus | Jun 15, 2020 | Offer document | SEC |
| 10-Q · Quarterly report | Jun 11, 2020 | Quarterly report | SEC |
| 8-K · Current report | Jun 11, 2020 | Results | SEC |
| 8-K · Current report | May 21, 2020 | Material contract | SEC |
| 4 · Change in ownership | May 19, 2020 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2020 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2020 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2020 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2020 | Insider trade | SEC |
| 424B3 · Prospectus | Mar 13, 2020 | Offer document | SEC |
| 4 · Change in ownership | Mar 12, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2020 | Insider trade | SEC |
| 10-Q · Quarterly report | Mar 12, 2020 | Quarterly report | SEC |
| 8-K · Current report | Mar 12, 2020 | Results | SEC |
| 4 · Change in ownership | Feb 10, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2020 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Feb 6, 2020 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Feb 6, 2020 | Insider trade | SEC |
| 8-K · Current report | Feb 4, 2020 | Meeting outcome | SEC |
| 4 · Change in ownership | Jan 31, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Jan 31, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Jan 31, 2020 | Insider trade | SEC |
| DEF 14A · Proxy statement | Dec 19, 2019 | Meeting notice | SEC |
| 424B3 · Prospectus | Dec 17, 2019 | Offer document | SEC |
| 10-Q · Quarterly report | Dec 13, 2019 | Quarterly report | SEC |
| 8-K · Current report | Dec 13, 2019 | Results | SEC |
| 8-K · Current report | Nov 20, 2019 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Nov 5, 2019 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Oct 31, 2019 | Offer document | SEC |
| 10-K · Annual report | Oct 29, 2019 | Annual report | SEC |
| 8-K · Current report | Oct 29, 2019 | Results | SEC |
| 4 · Change in ownership | Oct 3, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2019 | Insider trade | SEC |
| 8-K · Current report | Oct 3, 2019 | Material contract | SEC |
| 5 · Annual statement of ownership | Aug 6, 2019 | Insider trade | SEC |
| 8-K · Current report | Aug 2, 2019 | Material contract | SEC |
| 8-K · Current report | Jul 31, 2019 | Management or board change | SEC |
| 8-K · Current report | Jul 19, 2019 | Material contract | SEC |
| 8-K · Current report | Jul 12, 2019 | Management or board change | SEC |
| 8-K · Current report | Jun 26, 2019 | Material contract | SEC |
| 4/A · Change in ownership, amended | Jun 25, 2019 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 25, 2019 | Insider trade | SEC |
| 8-K · Current report | Jun 25, 2019 | Material contract | SEC |
| 424B3 · Prospectus | Jun 14, 2019 | Offer document | SEC |
| 10-Q · Quarterly report | Jun 13, 2019 | Quarterly report | SEC |
| 8-K · Current report | Jun 13, 2019 | Results | SEC |
| 4 · Change in ownership | May 13, 2019 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2019 | Insider trade | SEC |
| 8-K · Current report | May 13, 2019 | Material contract | SEC |
| 4 · Change in ownership | Mar 7, 2019 | Insider trade | SEC |
| 424B3 · Prospectus | Mar 7, 2019 | Offer document | SEC |
| 10-Q · Quarterly report | Mar 6, 2019 | Quarterly report | SEC |
| 8-K · Current report | Mar 6, 2019 | Results | SEC |
| 8-K · Current report | Feb 21, 2019 | Material contract | SEC |
| 4 · Change in ownership | Feb 21, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2019 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 6, 2019 | Insider trade | SEC |
| 8-K · Current report | Feb 1, 2019 | Management or board change | SEC |
| DEF 14A · Proxy statement | Dec 20, 2018 | Meeting notice | SEC |
| 424B3 · Prospectus | Dec 14, 2018 | Offer document | SEC |
| 10-Q · Quarterly report | Dec 13, 2018 | Quarterly report | SEC |
| 8-K · Current report | Dec 13, 2018 | Results | SEC |
| 424B3 · Prospectus | Nov 13, 2018 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Nov 1, 2018 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Oct 25, 2018 | Offer document | SEC |
| 10-K · Annual report | Oct 25, 2018 | Annual report | SEC |
| 8-K · Current report | Oct 25, 2018 | Results | SEC |
| 3 · Initial statement of ownership | Oct 12, 2018 | Insider trade | SEC |
| 8-K · Current report | Oct 9, 2018 | Management or board change | SEC |
| 8-K · Current report | Sep 7, 2018 | Management or board change | SEC |
| 4 · Change in ownership | Aug 20, 2018 | Insider trade | SEC |
| 8-K · Current report | Aug 16, 2018 | Material contract | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from PURE Bioscience’s releases · as of Oct 29, 2026
- Common shares
- 140,201,055
- Fully diluted
- 140,201,055
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 140,201,055 | Oct 29, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 29, 2026 | 140,201,055 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Craig Johnson Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 7, 2024); Heron Therapeutics, Inc. (Lead Independent Director · Since at least Jan 10, 2014); La Jolla Pharmaceutical Co (Director · Oct 14, 2013 – Aug 22, 2022 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past); Ardea Biosciences Inc (Director · Jan 3, 2011 – Jun 19, 2012 · Past) | Chief Financial Officer · Aug 1, 2011 – Aug 1, 2011 · Past |
| Peter C. Wulff Other companies: GlucoTrack, Inc. (Chief Financial Officer · Jan 28, 2025 – Nov 5, 2026 · Past); Alphatec Holdings, Inc. (CFO, VP and Treasurer · Jun 16, 2008 – Aug 10, 2010 · Past) | CFO, COO & Secretary · Nov 5, 2012 – Oct 23, 2013 · Past |
| Gregory Hurd Barnhill Other companies: Osiris Therapeutics Inc (Director · Aug 3, 2006 – Mar 23, 2012 · Past) | Director · Apr 12, 2006 – Jul 31, 2012 · Past |
| Janet Risi Field Other companies: Onterris, Inc. (Director · Since at least Oct 19, 2021) | Director · Jul 27, 2017 – Feb 26, 2018 · Past |
| Kristin Taylor Other companies: ImageWare Systems Incorporated (PRESIDENT & CEO · Apr 16, 2021 – Apr 16, 2021 · Past) | Director · Jan 20, 2021 – Sep 30, 2022 · Past |
| Bernard Blotner | Board Member · Since at least Feb 8, 2023 |
| Darin Zehr | Board Member · Since at least Nov 5, 2026 |
| David M. Rendall | Board Member · Since at least Jan 20, 2021 |
| Dennis Brovarone | Director · Oct 16, 2008 – Jul 31, 2012 · Past |
| Donna Singer | Vice President/Asst Secretary, Director · May 6, 2010 – Jan 24, 2013 · Past |
All 23 people
| Person | Seat |
|---|---|
| Gary Brownell | Director · Apr 12, 2006 – Feb 14, 2008 · Past |
| Gary Cohee | Director · Aug 13, 2013 – Feb 26, 2018 · Past |
| Ivan Chen | Chairman of the Board · Since at least Jun 28, 2018 |
| Jeff Kitchell | President, · Since at least Nov 19, 2025 |
| Jeffrey Scott Kitchell | President, Corporate Secretary · Since at least Nov 17, 2025 |
| John J Carbone | Director · Mar 3, 2009 – Jul 31, 2012 · Past |
| Mark Stuart Elliott | Vice President, Finance · Jul 31, 2015 – Aug 20, 2024 · Past |
| Michael L Krall | Chief Executive Officer, Director · Jan 24, 2013 – Jan 24, 2013 · Past |
| Robert Bartlett | CEO · Since at least Feb 8, 2023 |
| Tim Steffensmeier | Vice President of Sales · Jun 2, 2025 – Nov 4, 2026 · Past |
| Tom Myers | Board Member · Since at least Oct 4, 2018 |
| Tom Y. Lee | Board Member · Since at least Jul 15, 2022 |
| William Otis | Director · Oct 8, 2013 – Feb 26, 2018 · Past |
Log in to ask 6ix AI your own questions about PURE Bioscience.